Salute e Benessere
SciBase initiates sales collaboration in Italy
Michelangelo Simonelli , CEO at Kilabs, is spearheading the introduction of Nevisense in Italy Under Simonelli's leadership leveraging on a team of recognized experts in the field such as Alessandro Cappella and Giuseppe Romano , Kilabs is working to integrate Nevisense into clinical practice, offering a more accurate and non-invasive method for early melanoma detection, which could significantly improve patient outcomes in the field of dermatology. This initiative underscores Kilabs' commitment to innovation and improving healthcare standards in Italy .
"I am really very proud to be part of a lifesaving project to address the critical issue of melanoma in Italy . I firmly believe Kilabs will play a crucial role in securing appropriate deployment of Nevisense thanks to our high expertise and introduction in the field," says Michelangelo Simonelli CEO of Kilabs Srl.
"I look forward to a very exciting collaboration. During the year, we have met with Italian doctors and tested the interest in the technology together with our partner, and I look forward to being able to offer patients in Italy better diagnostics and care together with Kilabs. Kilabs will start preparing the market now to be ready to launch Nevisense when the regulatory adjustments are in place. We will thus be able to give more patients access to Nevisense," says Pia Renaudin , CEO of SciBase.
Pia Renaudin , CEO, tel. +46732069802, e-mail:
pia.renaudin@scibase.com
Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
This information was brought to you by Cision http://news.cision.com .
https://news.cision.com/scibase/r/scibase-initiates-sales-collaboration-in-italy,c4058870
The following files are available for download:
View original content: https://www.prnewswire.co.uk/news-releases/scibase-initiates-sales-collaboration-in-italy-302291516.html